Microsoft Excel LibreOffice Calc

Pfizer Inc. (NYSE:PFE)

Paying users zone. Data is hidden behind: .

We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Verified by Visa MasterCard SecureCode American Express SafeKey
Unlock

This is a one-time payment. There is no automatic renewal.

Common-Size Income Statement

Beginner level

Pfizer Inc., common-size consolidated income statement

Microsoft Excel LibreOffice Calc
12 months ended Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Revenues
Cost of sales
Gross profit
Selling, informational and administrative expenses
Research and development expenses
Amortization of intangible assets
Restructuring charges and certain acquisition-related costs
Operating income
Gain on completion of Consumer Healthcare JV transaction
Interest income
Interest expense
Net interest expense
Foreign currency loss related to Venezuela
Royalty-related income
Net gains on asset disposals
Net gains recognized during the period on equity securities
Net realized losses on sales of investments in debt securities
Income from collaborations, out-licensing arrangements and sales of compound/product rights
Net periodic benefit credits (costs) other than service costs
Certain legal matters, net
Certain asset impairments
Business and legal entity alignment costs
Net losses on early retirement of debt
GSK Consumer Healthcare JV equity method income
Other, net
Other income (deductions), net
Income from continuing operations before (provision) benefit for taxes on income
(Provision) benefit for taxes on income
Income from continuing operations
Income (loss) from discontinued operations, net of tax
Gain (loss) on disposal of discontinued operations, net of tax
Discontinued operations, net of tax
Net income before allocation to noncontrolling interests
Net income attributable to noncontrolling interests
Net income attributable to Pfizer Inc.
Preferred stock dividends, net of tax
Net income attributable to Pfizer Inc. common shareholders

Based on: 10-K (filing date: 2020-02-27), 10-K (filing date: 2019-02-28), 10-K (filing date: 2018-02-22), 10-K (filing date: 2017-02-23), 10-K (filing date: 2016-02-29).

Income statement item Description The company
Operating income The net result for the period of deducting operating expenses from operating revenues. Pfizer Inc.’s operating income as a percentage of revenues increased from 2017 to 2018 but then decreased significantly from 2018 to 2019.
Income from continuing operations before (provision) benefit for taxes on income Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Pfizer Inc.’s income from continuing operations before (provision) benefit for taxes on income as a percentage of revenues decreased from 2017 to 2018 but then increased from 2018 to 2019 exceeding 2017 level.
Net income attributable to Pfizer Inc. The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Pfizer Inc.’s net income attributable to Pfizer Inc. as a percentage of revenues decreased from 2017 to 2018 but then increased from 2018 to 2019 not reaching 2017 level.